TrialHuman vaccines & immunotherapeutics2018
Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials.
Yunda Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it